4G/5G Polymorphism of Plasminogen Activator Inhibitor-1 Gene and Disseminated Intravascular Coagulation in Severe Sepsis and Septic Shock
NCT01211899 · Status: UNKNOWN · Type: OBSERVATIONAL · Enrollment: 160
Last updated 2011-10-05
Summary
Data on 4G/5G polymorphism of plasminogen activator inhibitor-1 (PAI-1) gene are limited in Asian patients with sepsis. Therefore, the investigators aim to prospectively investigate the incidence of 4G/5G polymorphism and its relationship with disseminated intravascluar coagulatin in patients with severe sepsis and septic shock.
Conditions
- Severe Sepsis
Sponsors & Collaborators
-
Hallym University Medical Center
lead OTHER
Eligibility
- Min Age
- 18 Years
- Sex
- ALL
- Healthy Volunteers
- No
Timeline & Regulatory
- Start
- 2010-09-30
- Primary Completion
- 2012-09-30
More Related Trials
-
Identification of Markers of Poor Clinical Prognosis in Sepsis by Epigenetic Analysis
NCT06446947 ·Status: RECRUITING
-
Interest of the Balance of Pro-coagulating and Profibrinolytis Activities of the Microparticles (MP) in the Prognosis of Septic Shock
NCT02062970 ·Status: UNKNOWN ·Phase: NA
-
Efficacy and Safety of Unfractionated Heparin on Severe Sepsis With Suspected Disseminated Intravascular Coagulation
NCT02654561 ·Status: RECRUITING ·Phase: PHASE3
-
The Diagnostic and Prognostic Value of TAT, PIC, tPAI·C and TM in Sepsis-induced Coagulopathy
NCT06379126 ·Status: NOT_YET_RECRUITING
-
The Impact of Coagulation Disorders on the Diagnosis and Prognosis of Sepsis
NCT05998733 ·Status: UNKNOWN
-
Lactate Clearance According to the Presence of Hepatic Dysfunction
NCT01709565 ·Status: UNKNOWN
-
Stress Doses of Hydrocortisone on Coagulation Dysfunction in Patients With Septic Shock
NCT02266589 ·Status: COMPLETED ·Phase: PHASE3
-
Characterization of Hemostatic Disordres in Septic Shock: Searching for Biological Markers
NCT02692053 ·Status: UNKNOWN ·Phase: NA
-
Study Assessing Efficacy of Plasmatherapy in Septic Shock-induced Coagulopathy: Feasibility Study
NCT04580563 ·Status: COMPLETED ·Phase: NA
-
The Correlation Between The New Sepsis Scores - SOFA, Quick SOFA and Calibrated Automated Thrombogram Values
NCT02953002 ·Status: COMPLETED
-
Methylene Blue in Severe Sepsis and Septic Shock
NCT01797978 ·Status: UNKNOWN ·Phase: PHASE3
-
Researching the Effects of Sepsis on Quality Of Life, Vitality, Epigenome and Gene Expression During RecoverY From Sepsis
NCT05052203 ·Status: UNKNOWN
-
Prolonged Intravenous Infusion of β-lactam Antibiotics in Early Septic Patients
NCT05024565 ·Status: UNKNOWN ·Phase: NA
-
Effect of Hyperglycemia in PAI-1 Activity and the Relationship With Outcome in Severe Sepsis and Septic Shock
NCT00159952 ·Status: COMPLETED ·Phase: PHASE2/PHASE3
-
Effects of Stress Doses of Hydrocortisone on Coagulation Dysfunction in Patients With Septic Shock
NCT02114710 ·Status: COMPLETED ·Phase: PHASE3
-
A Study to Learn About How Safe BAY 3389934 is, Its Suitable Dose, and How it Affects the Participants With Sepsis Induced Coagulopathy
NCT06854640 ·Status: RECRUITING ·Phase: PHASE1
-
The Predictive Value of Hepatocyte Growth Factor and Soluble Receptor s-Met in Sepsis
NCT03340649 ·Status: UNKNOWN
-
Investigate the Activity of Endotoxin in Severe Sepsis
NCT01957254 ·Status: TERMINATED
-
Combined Determination of sTREM-1, PCT and CD64 in Diagnosing Sepsis
NCT02198950 ·Status: COMPLETED
-
Sodium Status in Septic Patients and Its Relation to Prognosis an Hospital Stay
NCT04564508 ·Status: UNKNOWN
-
TREM-1 Gene Polymorphisms
NCT01490424 ·Status: COMPLETED
-
Registration of Sepsis Patients in the Emergency Department
NCT06068192 ·Status: NOT_YET_RECRUITING
-
Study on the Construction and Application of Early Warning Model of Sepsis in Critically Ill Patients
NCT06904001 ·Status: ENROLLING_BY_INVITATION
-
Gut Microbiome Dysbiosis in Sepsis-induced Coagulopathy
NCT04525677 ·Status: UNKNOWN
-
Use of Fc-MBL to Detect and Monitor the Presence of PAMPs During Septic Shock
NCT03457038 ·Status: UNKNOWN ·Phase: NA